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Poisonings by waterblooms of toxic cyanobac-
teria (cyanobacteria toxin poisonings; CTP)
are a significant part of the concern over
harmful algal blooms (1–4). The toxins,
called cyanotoxins, are responsible for inter-
mittent but repeated widespread poisonings
of wild and domestic animals and aquacul-
tured fish. Cyanotoxins include neurotoxic
anatoxin-a and anatoxin-a(s), paralytic shell-
ﬁsh poisons (PSP; saxitoxin and analogues),
and hepatotoxic microcystins, nodularins, and
cylindrospermopsins (1). Human poisonings
have, in the past, been suspected but not con-
ﬁrmed due to a lack of information regarding
vectors or circumstances that would conﬁrm
the presence of cyanotoxins in human food or
water supplies, plus a shortage of appropriate
methods of detection. Because most CTP
occur only when waterblooms accumulate as
thick surface scums, humans do not experi-
ence acute intoxication because they generally
avoid contact with such high cell concentra-
tions. In addition, drinking water supplies
usually receive a degree of treatment that pre-
vents high concentrations of cyanotoxins
from being present. This spares humans from
severe poisoning episodes by the oral route.
However, the oral route of exposure is not the
only one possible for humans. This article
provides biological and chemical evidence for
the first documented lethality to humans
from cyanobacterial hepatotoxins, occurring
via the intravenous route, in a dialysis clinic in
the city of Caruaru, Brazil, during 1996.
Caruaru is a city of about 350,000 people
2 hr west of Recife, the capital of the
Brazilian state of Pernambuco. Two renal
dialysis centers (A and B) serve the popula-
tion, with center A receiving water from the
city’s water treatment plant, which is deliv-
ered by truck. Center B obtains reticulated
water from the city’s water treatment plant.
Beginning on 13 February 1996, center A
patients receiving routine renal dialysis treat-
ment began to complain of headache, eye
pain, blurred vision, nausea, and vomiting.
The first patient died suddenly on 20
February at center A. Fifty-one patients died
by the middle of April, and a total of 76
deaths were reported in the course of our
studies, which ended in October 1997.
Through the cooperation of health and med-
ical authorities in Pernambuco and the
Centers for Disease Control (CDC) in
Atlanta, Georgia, we obtained liver samples
from 52 of these 76 victims. From these case
reports, a pattern of disease was described
that is now referred to as Caruaru syndrome.
Caruaru syndrome is characterized by
painful, extreme hepatomegaly, jaundice, and
a bleeding diathesis manifested by ecchymo-
sis, epistaxis, and methrorrhagia; elevated
transaminases, variable hyperbilirubinemia,
prolonged prothrombin time, and severe
hypertrigliceridemia; and disruption of liver
plates, liver cell deformity, necrosis, apoptosis,
cholestasis, cytoplasmic vacuolization, mixed
leukocyte infiltration and multinucleated
hepatocytes observed upon light microscopy
and intracellular edema, mitochondrial
changes, rough and smooth endoplasmic retic-
ulum injuries, lipid vacuoles, and residual bod-
ies observed upon electron microscopy (5–7).
This outbreak received much attention
from the media and public health authorities
in Brazil and has been reported in many coun-
tries. The background of this case and a sum-
mary of the epidemiology have been published
(6,7). Over the intervening period, we have
examined the limnological and case report
data and analyzed most of the liver tissues pro-
vided and some of the serum samples. These
results have allowed us to address some impor-
tant questions regarding these human fatali-
ties: What were the possible toxigenic
cyanobacteria present in the reservoir that sup-
plied water to Caruaru and the dialysis clinic?
Which cyanotoxins were present, and at what
concentrations? Were the concentrations of
cyanotoxins present in the dialysis center high
enough to produce liver failure and death?
Materials and Methods
Phytoplankton collections and identiﬁcations.
Water treatment personnel were not doing
phytoplankton counts or identiﬁcation during
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An outbreak of acute liver failure occurred at a dialysis center in Caruaru, Brazil (8°17’ S, 35°58’ W),
134 km from Recife, the state capital of Pernambuco. At the clinic, 116 (89%) of 131 patients
experienced visual disturbances, nausea, and vomiting after routine hemodialysis treatment on
13–20 February 1996. Subsequently, 100 patients developed acute liver failure, and of these 76
died. As of December 1996, 52 of the deaths could be attributed to a common syndrome now
called Caruaru syndrome. Examination of phytoplankton from the dialysis clinic’s water source,
analyses of the clinic’s water treatment system, plus serum and liver tissue of clinic patients led to
the identification of two groups of cyanobacterial toxins, the hepatotoxic cyclic peptide micro-
cystins and the hepatotoxic alkaloid cylindrospermopsin. Comparison of victims’ symptoms and
pathology using animal studies of these two cyanotoxins leads us to conclude that the major con-
tributing factor to death of the dialyses patients was intravenous exposure to microcystins, speciﬁ-
cally microcystin-YR, -LR, and -AR. From liver concentrations and exposure volumes, it was
estimated that 19.5 µg/L microcystin was in the water used for dialysis treatments. This is 19.5
times the level set as a guideline for safe drinking water supplies by the World Health
Organization. Key words: cyanobacteria, cyanotoxins, cylindrospermopsins, microcystins, toxins.
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http://ehpnet1.niehs.nih.gov/docs/2001/109p663-668carmichael/abstract.htmlthe month of February 1996, and so samples
of phytoplankton were not available from the
time of the initial outbreak. Subsurface phyto-
plankton samples from Tabocas Reservoir
(Caruaru water supply) were, however, col-
lected retrospectively at the end of March
1996, identiﬁed, and quantiﬁed. Subsamples
used for phytoplankton identification and
quantification were preserved with Lugol’s
iodine solution. Direct counting of preserved
cells was carried out with Utermohl’s counting
techniques using a counting chamber and
inverted microscope.
Analyses for cyanotoxins. Samples of car-
bon, sand, and cation/anion exchange resin
from the in-house filters at both clinics A
and B were analyzed using a polyclonal anti-
body against the cyclic peptide hepatotoxins,
the microcystins, in an enzyme-linked
immunosorbant assay (ELISA) (8,9). This
antibody was raised against microcystin-LR
but cross-reacts with many of the known
microcystin analogues. Blood sera and liver
from affected and control patients provided
by state health personnel in Pernambuco and
sent through the CDC were also examined
by ELISA (see tissue extraction method,
below). Samples of carbon, cation and anion
exchange resin, and sand from clinic A and
carbon and sand from clinic B were extracted
3 times with 10 volumes of 100% methanol
for 12 hr. Extracts were dried and resus-
pended in distilled water and applied to C18
cartridges (6 mg). Deionized water and 20
and 100% methanol eluates were collected
and dried. The 100% methanol extracts
(both filter and tissue extracts) were resus-
pended in 1:1 methanol/H2O and diluted
10–1, 10–2, and 10–3 with phosphate-
buffered saline and assayed by ELISA.
We used 52 liver samples representing 39
victims (covering February–December 1996)
in our analyses (13 replicate samples were
also analyzed). Liver samples were homoge-
nized in 100% methanol (2 times over 24 hr)
using a volume of 10 mL for liver < 1 g and
10 mL/g for tissue > 1 g. Extracts were cen-
trifuged at 7000 × g. Methanol supernatants
were combined and mixed with a 3-times
volume of hexane. The hexane layer was dis-
carded and the methanol extract was placed
in 40 mL distilled water and applied to C18
silica cartridges. Water and 20 and 100%
methanol eluates were collected. The 100%
methanol extracts were dried, resuspended in
1:1 methanol/H2O, and diluted 10–1, 10–2,
and 10–3 with phosphate-buffered saline and
assayed by ELISA.
We used 17 serum samples representing
12 victims in our analyses reported here.
Serum samples (200 µL–1.0 mL) were
diluted 4 times with double-distilled H2O,
and the diluted serum was loaded onto a
C18 silica cartridge. The C18 cartridge was
processed as described above for liver sam-
ples and assayed by ELISA.
We obtained control liver samples from
five persons from the pathology unit at the
Federal University of Pernambuco. These
samples represented persons not associated
with dialysis treatment in Caruaru. Control
sera (n = 12) were from volunteer health per-
sonnel in Caruaru, Recife, and Atlanta.
These samples were extracted for analyses in
the same way as victim samples were.
Chemical analyses for microcystins in
liver and serum samples were done by ELISA-
guided HPLC-photodiode array (PDA) sepa-
ration of microcystins from liver tissues.
HPLC chromatograms were obtained on a
Waters 2690 Millennium system (Waters,
Milford, MA, USA). HPLC column condi-
tions were: column, Waters µ Bondapak C18,
3.9 × 300 mm; mobile phase, isocratic-60%
methanol/40% 0.05% trifluoroacetic acid;
ﬂow rate, 1 mL/min, Waters 996 PDA detec-
tor. The separated microcystins were further
analyzed by matrix-assisted laser desorption
ionization/time of ﬂight (MALDI/TOF) and
electrospray ionization (ESI) mass spectrom-
etry (MS). MALDI spectra were acquired on
a VG TofSpec mass spectrometer (VG
Analytical Fisons Instruments, Manchester,
UK) in the linear mode, using a 337 nm N2
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Table 1. Phytoplankton counts from Tabocas reservoir.
Total Cyanobacteria/mL
Samples from reservoir, March 1996 phytoplankton/mL (% of total phytoplankton)
Center 40,000 39,731 (99.3)
Margin 13,190 13,100 (99.3)
Raw water impounded to water treatment plant 21,420 20,882 (97.5)
Figure 1. Quantitative analysis of phytoplankton in raw water received at the Caruaru city water treatment plant. (A)
Database from 1990 to 1995. (B) Database from March 1996 to April 1996. Data were provided by the State of Pernambuco
Water Treatment Company (COMPESA).
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Table 2. Microcystin (by ELISA) and cylindrospermopsin (by LC/MS/MS) content of carbon, ion-exchange
resin, and sand ﬁlters from dialysis centers A and B in Caruaru, Brazil.
Center/sample source Microcystin (µg/g) Cylindrospermopsin (µg/g)
Center A, carbon 1.0 19.70
Center A, anion resin 0.5 0.02
Center A, cation resin 2.1 0.05
Center A, sand ND ND
Center B, carbon 3.4 ND
Center B, sand ND ND
ND, not detected.
Table 3. Microcystin values, by ELISA, of liver and serum from Caruaru dialysis patients.
No. of victims/no.of samples Mean microcystin (ng/g)
Month of death (1996)
February 4/7 257.7
March 11/14 255.4
April 8/12 179.6
May 3/4 272.5
July 1/1 471.8
August 4/6 216.8
September 3/3 219.9
October 2/2 50.2
December 1/1 160.4
Patients without date of death  2/2 145.9
Total no. patients/no. samples 39/52 223
Mean of serum valuesa 12/17 2.2 (ng/mL)
aValues from victims who died and who also had positive liver values.laser. The MALDI/TOF ionization method
has emerged as a powerful analytical method
(10), with a high sensitivity and tolerance for
small amounts of salt and buffer that allow
low-level detection of analyses (sub-femto-
mole) in complex mixtures. The thin-film
coating method was used in these analyses
(11). ESI spectra were acquired on a VG
Quattro mass spectrometer (VG Biotech,
Fisons, Manchester, UK). Cesium chloride
was used for the calibration.
During the time in which microcystins
were being analyzed, it became apparent that
we should also examine the samples for other
cyanotoxins. After the first analyses for
microcystins, other studies demonstrated a
wide occurrence of Cylindrospermopsis
(Anabaenopsis) in Brazil. Because this
cyanobacterium is capable of producing the
alkaloid hepatotoxin cylindrospermopsin
(CYN) and deoxy-cylindrospermopsin
(deoxy-CYN), analyses for this cyanotoxin
were begun in 1998. For CYN/deoxy-CYN
analysis of sand, carbon, and ion exchange
resins, methanolic extracts (5 g of sample in
20 mL of 100% methanol) were dried under
nitrogen gas and the residue taken up in 1:5
methanol/H2O. Due to limited amounts of
liver and sera for a given victim, extracts for
CYN analyses were the same as those used
for microcystin (MCYST) analyses. This
extract was ﬁltered and dilutions performed
as needed to maintain a response in the linear
range of the calibration curve. Analyses were
by HPLC/MS/MS using a PE/Sciex API 300
mass spectrometer with turbo-ion spray
interface coupled to a Perkin Elmer series
200 HPLC system (Applied Biosystems,
Foster City, CA, USA). HPLC separation
was achieved on a 150 × 4.6 mm Alltima
C18 column (Alltech Associates, Sydney,
Australia) run at 35°C. The efﬂuent was split
to achieve a ﬂow rate of 0.25 mL/min to the
MS. The MS was operated in the multiple-
reaction monitoring mode using nitrogen gas
as the collision gas. The transition 416.2 to
194 Da was used to determine CYN concen-
tration, and the transition 400.2 to 194 Da
was used for deoxy-CYN. The limit of detec-
tion with the method was 0.01 ng/g (12).
Results
Phytoplankton analyses. Analysis of phyto-
plankton from the Tabocas Reservoir at the
end of March 1996 demonstrated that toxi-
genic cyanobacteria were the main phyto-
planktic group, representing 99% of the
total density of phytoplankton. The average
number of cyanobacterial organisms was
24,500/mL (Table 1). Some cyanobacterial
picoplanktonic strains isolated from water
samples of Tabocas Reservoir after the out-
break were identiﬁed as MCYST producers
by HPLC and ELISA (13). However,
because the water utility was not making
phytoplankton counts at the time of the out-
break, toxic cyanobacteria producing micro-
cystin or other cyanotoxins during the
period of intoxication could not be exam-
ined. An evaluation of previous years’ phyto-
plankton data showed that cyanobacteria
were dominant in the reservoir during the
summer months since at least 1990 (Figure
1). The most common genera during this
time period were Microcystis, Anabaena, and
Anabaenopsis (Cylindrospermopsis). Other
studies confirm that toxic cyanobacteria,
especially Cylindrospermopsis, are present in
other Brazilian water supplies (14–16).
Microcystis and Anabaena are known produc-
ers of microcystins, while Cylindrospermopsis
can produce cylindrospermopsin. For this
reason we analyzed samples for these two
cyanotoxins. Although the literature reports
the neurotoxins anatoxin-a and a(s) to be
produced by Anabaena and certain PSPs to
be produced by Cylindrospermopsis (3), the
lack of reported neurotoxic symptoms in
most of the Caruaru victims meant that
these toxins were not likely present and
therefore we did not analyze samples for
those toxins.
Analyses for cyanotoxins. Examination of
carbon, sand, and cation/anion resin exchange
ﬁlters from the clinic using a polyclonal anti-
body in an ELISA against microcystin-LR
showed microcystin in the microgram per
gram range (Table 2). Further examination of
methanolic extracts from these carbon, sand,
and resins performed by HPLC-electrospray
MS/MS provided chemical evidence for CYN
contamination in this material. The highest
concentration of this hepatotoxic alkaloid was
found in the carbon extract (Table 2).
Blood sera and liver from affected and
control patients provided by state health ofﬁ-
cials in Pernambuco and sent through the
CDC were examined by ELISA. All patient
sera and tissue were positive for microcystins
(Table 3). ELISA-guided HPLC-PDA sepa-
ration of microcystins from liver tissues pro-
vided a profile of microcystins present
(Figure 2). MALDI/TOF (Figure 3) and ESI
(Table 4) MS analysis were used to identify
isolated microcystins from liver. Microcystins
Articles • Human fatalities from cyanotoxins
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Figure 2. HPLC/PDA spectrum from liver extract of a Caruaru dialysis patient. (A) Retention times of labeled peaks corre-
spond to retention times of authentic microcystin-YR, -LR, and -AR standards; detection was done at 238 nm. (B)
Microcystin peaks showing their characteristic 238-nm ultraviolet chromophore.
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-AR. MALDI MS analysis of ﬁnished water
from dialysis center B also showed the pres-
ence of these microcystins (data not shown).
Analysis of liver samples for CYN by
HPLC-MS/MS did not reveal the parent
compound at molecular mass 416 (M+H).
These liver extracts had been prepared for
MCYST analyses, and the method may not
have selected for the more polar alkaloid
CYN. Due to limited sample availability,
further analyses of remaining liver tissue and
sera for CYN is pending while a method is
developed for detecting this cyanotoxin in
these matrices.
Calculation of microcystin exposure. The
average microcystin value in 52 liver samples
from 39 victims who died from February to
December 1996 was 223 ng/g (Table 3).
This compares well with values reported in
laboratory test animals receiving acute expo-
sure of microcystin-LR (17). ELISA detected
125 ng/g of microcystin-LR in the livers of
mice exposed to a lethal intraperitoneal injec-
tion of 100 µg/kg (18). We used the average
liver concentration of 223 ng/g to estimate
the amount of microcystin present in the
source water from clinic A. Using an average
liver weight for an adult human of 1,500 g
gives 335 µg of possible MCYST burden in
an average liver from the Caruaru victims.
We then used two correction factors that
could affect the amount of MCYST in the
source water. The first was the amount of
MCYST in the liver as a percentage of the
total exposure. Laboratory experiments indi-
cate that from 10% to 90% of the total expo-
sure can be found in the liver of mice and
rats receiving an acute or lethal dose of
MCYST (19,20). Therefore, an application
factor of 2 (estimate of 50% uptake in the
liver) was used. The second factor was based
on the ﬁnding that since microcystin is cova-
lently bound to protein phosphatase 1 and
protein phosphatase 2A, as much as 80% of
the MCYST exposure might not be recog-
nized by the ELISA assay (21,22). Although
this estimate is conservative, it means that the
MCYST exposure might have been about 7
times higher (2 times and 5 times, respec-
tively). Using this value and dividing by the
amount of water used during a typical dialy-
sis treatment (120 L), and assuming 100%
dialysis of MCYST across the hollow fiber
dialysis ﬁlter gives an estimated concentration
in the source water of 19.5 µg/L. Although
there are several assumptions in estimating
this value, it does mean that an environmen-
tally feasible level of MCYST in the source
water would have been adequate to cause
acute liver failure and death in humans by
the intravenous route. If this concentration
of MCYST is an accurate estimate, then
there was no signiﬁcant contribution to the
toxicity from CYN. This MCYST value is
about 20 times higher than the 1 µg/L pro-
posed by the World Health Organization as a
safe level for oral consumption of MCYST in
drinking water (23).
Histology and pathology of liver tissues
revealed a pattern of liver plate disruption
identical to that found in previous laboratory
animal experiments of microcystin exposure
(5,24–26). MCYSTs are potent inhibitors of
eukaryotic protein serine/threonine phos-
phatases 1 and 2A (27,28). Substances that
inhibit these protein phosphatases are 
considered to be nonphorbal ester-type
tumor promoters (29,30). This means that
survivors of Caruaru syndrome could be at
higher risk for liver cancer and should be
monitored (3); however, the degree to which
CYN contributed to the deaths of the dialysis
patients is less clear. Until we can evaluate
whether CYN is present in the victims’ livers,
we cannot estimate the possible toxicity due
to this cyanotoxin. CYN is a hepatotoxic
alkaloid first studied from Australian water
supplies. In a retrospective study it has been
held as the cause of hepatoenteropathy and
Articles • Carmichael et al.
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Figure 3. MALDI/TOF-MS of liver extract from a Caruaru dialysis patient. (A) HPLC/PDA fractions obtained
at retention times at about 7 min showed a peak at m/z 1045, [M+H]+, the molecular ion of microcystin-YR.
This spectrum also shows the 995 peak of microcystin-LR, which can be explained by the unresolved peaks
from the HPLC proﬁle in Figure 2. (B) Fractions collected at 8 min showed a peak at m/z 995 (microcystin-
LR) and its fragment ion peak at m/z 860. The m/z 860 peak was due to a loss of Adda [PhCH2CH(OMe)+]
residue from the molecular ion, [M+H]+ = 135. (C) Microcystin-AR, eluted last (9–10 min) and showed a peak
at m/z 954 plus its fragment ion at m/z 818. Peaks observed at the low molecular weight region (m/z < 450)
are due to the matrix used for the analysis. The six other patient livers analyzed showed a similar pattern.
The accuracy of the method was estimated to be within 0.1% (1 mass unit for a molecular weight of 1,000).
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860.6renal damage to 148 indigenous peoples using
an Australian water supply (31). Comparison
of the Caruaru victims’ livers with published
studies in animals dosed with CYN did not
reveal a pattern indicating that this toxin con-
tributed to the toxicity. Because the victims in
Caruaru were undergoing renal dialysis, we
cannot evaluate whether CYN contributed to
renal toxicity. A better understanding of CYN
toxicology and biochemistry, both alone and
in combination with MCYST, is needed
before we can confirm (or rule out) a con-
tributing toxicity factor from this toxin.
Discussion
The available biological and chemical evi-
dence supports cyanotoxins from the Tabocas
Reservoir water supply as being the major fac-
tor in the deaths of dialysis patients at clinic
A. One important question was how could
lethal levels of MCYST (and possibly CYN)
be present in waters receiving standard water
treatment procedures including sedimenta-
tion, coagulation, ﬁltration, and chlorination?
The answer is that center A did not have
water directly piped to its facility. Instead,
they relied on water that was trucked to the
center for treatment in its in-house water sys-
tem—a process that involved sand ﬁltration,
carbon ﬁltration, and cation/anion exchange
ﬁltration, followed by a microﬁlter. Because
removal of chlorine residues was poor, due
most likely to inadequate maintenance of the
dialysis center in-house water treatment sys-
tem, center A maintenance staff used water
from the city’s water treatment system that
had received only alum ﬂoculation in order to
avoid chlorine residues in the dialysis treat-
ment water. This water, without the full ben-
eﬁt of water treatment, contained high levels
of cyanotoxins that were not removed by the
small, inadequately maintained, in-house
treatment facility of dialysis center A. This
center did not use reverse osmosis in its water
treatment process (32,33). Reverse osmosis is
used in several dialysis centers in Brazil and in
the United States and Europe. We conclude
that if reverse osmosis had been used, cyan-
otoxins would have been less likely to pass
through the ﬁltration process.
A newer dialysis center (center B) is also
present in Caruaru. Center B received water
piped from the municipal water plant that is
fully treated, except for carbon ﬁltration. No
fatalities that could be contributed to Caruaru
syndrome occurred at this center. However,
several patients at center B were reported to
have some symptoms of Caruaru syndrome
after the center used trucked water delivered
at the end of March. MCYST was identiﬁed
in the ﬁlter system of center B (Table 2) and
patients symptomatic for Caruaru syndrome
had MCYST in their serum.
One of the questions we have not been
able to address is the possibility of repeated
exposure to these cyanotoxins. It was not
until 7 March 1996, 15 days after the first
death, that center A was closed and dialysis
patients were sent to other center. Some of
these patients were sent to center B, where
there was also evidence of exposure to cyan-
otoxins. Therefore it is possible that multiple
exposures occurred. This makes it difﬁcult to
establish a dose–response effect. However, we
do think that most of the exposure to cyan-
otoxins came from one or two shipments to
center A, and we estimate that the primary
exposure to cyanotoxins was due to one to
three dialysis treatments. Another important
question is whether there may have been
some type of treatment that could have
removed or detoxified the exposure from
cyanotoxins that these dialysis patients expe-
rienced. Although there is no treatment for
MCYST or CYN exposure, another study
treated one clinic A patient with charcoal
hemoperfusion (7). Serum analyses of the
victim before and after hemoperfusion
showed a reduction of MCYST levels, as
measured by HPLC-photodiode array detec-
tor and ELISA, but levels rose after treat-
ment, and the patient died about 1 week
after the charcoal hemoperfusion. Liver sam-
ples from this victim were analyzed in our
study, and the level was 250 and 430 ng/g
(two separate liver samples).
We have learned signiﬁcant information
concerning human exposure from MCYST
and CYN in this ﬁrst conﬁrmed outbreak of
human poisoning involving cyanotoxins.
Because many of the world’s reservoir- and
lake-based water supplies are subject to
increasing levels of nutrients, it is highly
probable that repeat episodes of cyanotoxin
poisoning will occur unless measures are
taken to better understand their role in
water-based disease. These measures should
consist of programs for watershed manage-
ment to reduce nutrient inputs, cyanotoxin
monitoring programs to alert authorities to
the presence of cyanotoxins, and improve-
ments in water treatment techniques to
reduce or to remove cyanotoxins from
potable water supplies.
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